PRIMARY SCLEROSING CHOLANGITIS
Clinical trials for PRIMARY SCLEROSING CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SCLEROSING CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY SCLEROSING CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could cutting out gluten ease debilitating liver and gut disease?
Disease control OngoingThis study is exploring whether following a gluten-free diet can help control symptoms and slow disease progression in people with primary sclerosing cholangitis (a serious liver disease) and ulcerative colitis (a type of inflammatory bowel disease). Researchers will track 60 pat…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: NA • Sponsor: Institute for Clinical and Experimental Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug trial offers hope for rare liver disease
Disease control OngoingThis study is testing an experimental drug called CS0159 for people with Primary Sclerosing Cholangitis (PSC), a rare disease that scars the bile ducts in the liver. The main goal is to see if the drug is safe and if it can lower a key liver enzyme (ALP) over 12 weeks. The trial …
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for rare liver disease as experimental drug enters Mid-Stage trial
Disease control OngoingThis study is testing a drug called elafibranor in adults with primary sclerosing cholangitis (PSC), a rare disease that scars and blocks the liver's bile ducts. The main goal is to check the drug's safety and side effects. Researchers will also measure if it improves key liver b…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE2 • Sponsor: Ipsen • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Common cholesterol drug tested as potential lifeline for rare liver disease
Disease control OngoingThis large, late-stage study is testing whether a common cholesterol-lowering drug, simvastatin, can improve the long-term outlook for people with primary sclerosing cholangitis (PSC), a rare liver disease. About 570 adults with PSC will take either simvastatin or a placebo pill …
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE3 • Sponsor: Annika Bergquist • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug trial targets debilitating itch in liver disease
Symptom relief OngoingThis study is testing whether an investigational drug called volixibat can safely reduce the severe itching (pruritus) experienced by people with primary sclerosing cholangitis (PSC), a chronic liver disease. The trial involves 182 participants who will receive either the drug or…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC